[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma

• Authors:
  • Min Li
  • Mingyue Xia
  • Ziyu Zhang
  • Yanyin Tan
  • Enjie Li
  • Zhigang Guo
  • Mingzhi Fang
  • Yong Zhu
  • Zhigang Hu

• View Affiliations

  
  Affiliations: Department of Oncology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu 210023, P.R. China, National Centre of Colorectal Disease, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
• Published online on: July 24, 2023     https://doi.org/10.3892/ijo.2023.5549
• Article Number: 101

• Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1